Combination of mTOR and MAPK Inhibitors—A Potential Way to Treat Renal Cell Carcinoma

Author： Chauhan Ashutosh   Semwal Deepak Kumar   Mishra Satyendra Prasad   Goyal Sandeep   Marathe Rajendra   Semwal Ruchi Badoni  

Publisher： MDPI

E-ISSN： 2076-3271|4|4|16-16

ISSN： 2076-3271

Source： Medical Sciences, Vol.4, Iss.4, 2016-10, pp. : 16-16

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Cross-Talk in Cancer and Potential for Combination Therapy

By Conciatori Fabiana   Ciuffreda Ludovica   Bazzichetto Chiara   Falcone Italia   Pilotto Sara   Bria Emilio   Cognetti Francesco   Milella Michele  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

Role of mTOR Inhibitors in Kidney Disease

By Kajiwara Moto   Masuda Satohiro  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 975-975

MDPI

Access to resources Recommend Favorite

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif   Hashimi Saeed M.   Wei Ming Q.  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite

Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma

By Li Feng   Ma Zhenkun   Guan Zhenfeng   Chen Yule   Wu Kaijie   Guo Peng   Wang Xinyang   He Dalin   Zeng Jin  

International Journal of Molecular Sciences, Vol. 16, Iss. 4, 2015-04 ,pp. : 8415-8429

MDPI

Access to resources Recommend Favorite

11-epi-Sinulariolide Acetate Reduces Cell Migration and Invasion of Human Hepatocellular Carcinoma by Reducing the Activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR Signaling Pathways

By Lin Jen-Jie   Su Jui-Hsin   Tsai Chi-Chu   Chen Yi-Jen   Liao Ming-Hui   Wu Yu-Jen  

Marine Drugs, Vol. 12, Iss. 9, 2014-09 ,pp. : 4783-4798

MDPI

Access to resources Recommend Favorite